Tag: Research
-
$18 Million For Parkinson’s Disease Research to Study Brain Circuits Driving Symptoms
Northwestern University scientists have received two awards totaling nearly $18 million to address key knowledge gaps in the basic circuit mechanisms that contribute to the development and progression of Parkinson’s disease.
-
Study Finds Financial Incentives for Low-Risk Clinical Trials are Ethical
In one of two low-risk randomized clinical trials, financial incentives increased study participation, and the use of financial incentives in both trials were deemed not unethical, according to recent findings.
-
One Coronavirus Vaccine May Protect Against Other Coronaviruses
Coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses, paving the way for future universal coronavirus vaccines.
-
Anti-Cancer Inhibitor Could Have Dual Effect
TG2, an enzyme known to help cancers spread more quickly, also plays a role in regulating T-cells — opening the door to dual inhibition, according to a recent Northwestern Medicine study.
-
Lurie Cancer Center Receives Merit Extension from NCI
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a Merit Extension Award from the National Cancer Institute, one of only two Comprehensive Cancer Centers in the nation to earn the recognition.
-
For Every Man: Northwestern Investigators’ Critical Impact on Prostate Cancer
From teasing out determinants of health disparities to developing precision medicine treatments, clinicians and scientists from the Lurie Cancer Center are dramatically changing the landscape for all men with prostate cancer.
-
Study Identifies Expanded Role for Metabolic Enzyme in Kidney Cancer
The underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma, which accounts for 80 percent of all kidney cancers, according to a recent study.
-
Advancing Treatment for B-cell Acute Lymphoblastic Leukemia
Tisagenlecleucel, a chimeric antigen receptor (CAR) T-cell immunotherapy, demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia, according to recent findings.
-
Three Feinberg Faculty Elected to National Academy of Medicine
Elizabeth McNally, MD, PhD; Melissa Simon, MD, MPH; and Guillermo Ameer, ScD; have been elected to the National Academy of Medicine.
-
Lewy Body Dementia Exacerbated by Immune Response
T-cells respond to buildup of alpha-synuclein with a harmful auto-immune response, according to a Northwestern Medicine study published in Science.
